Stem cell gene therapy - search results

Prof Dr Freimut Schliess, Director of Science & Innovation at Profil Institut für Stoffwechselforschung GmbH explains the important role of innovation when it comes to healthy living and active ageing, including his thoughts on the diabetes paradigm

Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.

Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)

Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children

Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective

Paul De Raeve, Secretary General and Elisabeth Adams, President of the European Federation of Nurses Associations (EFN) tell us why the European Pillar of Social Rights should help nurses to remain in the nursing profession

Multiple breakthroughs in gene therapy offer new hope for patients with genetic blood disorder, most common in Middle Eastern, Mediterranean, South Asian and African populations

The role of advanced technologies in healthcare, including the work of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in this area, is placed under the spotlight by Open Access Government

The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government

Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.

Anna Knuuttila, Senior Scientist and Kaisa Helminen, CEO of Fimmic explain how artificial intelligence (AI) empowers pathologists when it comes to cancer care.

Ivan Stamenkovic, Professor of Experimental Pathology at University of Lausanne explores the paediatric sarcoma metastasis and why this warrants an in-depth look Metastasis is responsible for 90% of cancer–related death. Several solid paediatric malignancies, particularly sarcomas, display high metastatic proclivity, which renders their prognosis poor, as metastases are for the...

Eigil Kjeldsen from Aarhus University Hospital gives an expert perspective on the drive towards precision and targeted medicine for acute leukaemia

Cecilia Van Cauwenberghe, from TechVision Group, Frost & Sullivan provides a fascinating overview of acute respiratory distress syndrome, including refocusing clinical concerns and disease management, as well as the overall characteristics and health implications

Grazina Berry from Aplastic Anaemia Trust, along with Professor Judith Marsh and Dr Shreyans Gandhi from King’s College Hospital NHS Foundation Trust, explore the rare and serious condition of aplastic anaemia (AA)

Professor Michael Roth from the Department Biomedicine & Pneumology, at the University Hospital Basel, discusses development of medication for asthma and new asthma therapies. Asthma is the most common non-communicable chronic inflammatory disease of the lung worldwide with no cure available. In the 2016 EU Symposium on the Awareness of allergic diseases it...

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid leukaemia (AML) is the cancer of the myeloid precursor stem cells character­ised by the appearance of immature, abnormal myeloid cells in bone marrow and other...

Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government Acute myeloid leukaemia (AML) is a form of blood cancer, which affects the white blood cells known as myeloid cells. It is a rapidly progressing form of leukaemia. Blood cells are formed...

Chairman of The Pernicious Anaemia Society, Martyn Hooper MBE lifts the lid on the history, causes and diagnosis of the world’s forgotten disease From the time it was first described in the mid-nineteenth century, the cause and treatment of Pernicious Anaemia became the subject of some of the most inquisitive...

Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is an umbrella term for cancers of the white blood cells – ‘leuk’ means white and ‘aemia’ refers to a condition of the blood. 26 people are...